1.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 16 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GENE-C9504-14, NCI-V96-0810
|
|
2.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MRMC-CTCA-9705, GENE-C9707-14, NCI-V98-1440
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00008, MC998C, P30CA015083, CDR0000068503, MAYO-MC998C, NCI-312, NCT00012298
|
|
4.
|
Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18-55 Sponsor: NCI Protocol IDs: E-3997, E3997
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Completed Age: Not specified Sponsor: Other Protocol IDs: 2004-0113, NCT00493181
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 70 and under Sponsor: NCI, Other Protocol IDs: 1365.00, FHCRC-1365.00, NCI-G99-1622, CDR0000067395, NCT00004157
|